文献速递妇科

基因预测循环蛋白生物标志物与卵巢癌风险

Genetically predicted circulating protein biomarkers and ovarian cancer risk.
PubMed 文献 · Gynecol Oncol · 2020-11-25

该研究整合基因组与蛋白质组数据,利用INTERVAL研究中3301名健康个体的遗传变异预测1329种血浆蛋白水平,在OCAC的22406例上皮性卵巢癌病例和40941名对照中评估其与卵巢癌风险的关联。共发现26种蛋白的基因预测循环水平与卵巢癌风险相关(FDR<0.05),所有信号均由高级别浆液性组织学类型驱动,该类型占OCAC病例的58%。

要点

  • 26种蛋白的基因预测循环水平与上皮性卵巢癌风险相关(FDR<0.05)。
  • 所有关联信号均由高级别浆液性组织学类型驱动,占OCAC病例的58%。
  • 通路分析显示26种蛋白富集于7条生物学通路(Padjusted<0.05),包括Focal Adhesion-PI3K-Akt-mTOR和Notch信号。

核心结论

  • 识别出的26种蛋白进一步阐明了上皮性卵巢癌的病因,并代表有前景的新生物标志物,有待在直接测量卵巢癌患者队列血浆蛋白的研究中靶向验证。

研究设计与样本

  • 利用INTERVAL研究中3301名健康个体的胚系遗传变异(P<1.5×10-11)预测1329种血浆蛋白水平,在OCAC的22406例上皮性卵巢癌病例和40941名对照中进行关联检验,通过将OCAC研究的beta系数和标准误按INTERVAL的beta系数倒数加权。

主要发现

  • 共识别26种蛋白的基因预测循环水平与上皮性卵巢癌风险相关(FDR<0.05),包括MFAP2、SEMG2、DLK1、NTNG1以及由染色体9q34.2变异预测血浆水平的22种蛋白。
  • 所有26种蛋白关联信号均由与高级别浆液性组织学类型的关联驱动,该类型占OCAC病例的58%。
  • 区域基因组图确认26种蛋白的血浆蛋白水平与卵巢癌风险的遗传关联信号重叠。
  • 通路分析显示26种蛋白中富集7条生物学通路(Padjusted<0.05),突出Focal Adhesion-PI3K-Akt-mTOR和Notch信号的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Most women with epithelial ovarian cancer (EOC) are diagnosed after the disease has metastasized and survival in this group remains poor. Circulating proteins associated with the risk of developing EOC have the potential to serve as biomarkers for early detection and diagnosis. We integrated large-scale genomic and proteomic data to identify novel plasma proteins associated with EOC risk. METHODS: We used the germline genetic variants most strongly associated (P <1.5 × 10-11) with plasma levels of 1329 proteins in 3301 healthy individuals from the INTERVAL study to predict circulating levels of these proteins in 22,406 EOC cases and 40,941 controls from the Ovarian Cancer Association Consortium (OCAC). Association testing was performed by weighting the beta coefficients and standard errors for EOC risk from the OCAC study by the inverse of the beta coefficients from INTERVAL. RESULTS: We identified 26 proteins whose genetically predicted circulating levels were associated with EOC risk at false discovery rate < 0.05. The 26 proteins included MFAP2, SEMG2, DLK1, and NTNG1 and a group of 22 proteins whose plasma levels were predicted by variants at chromosome 9q34.2. All 26 protein association signals identified were driven by association with the high-grade serous histotype that comprised 58% of the EOC cases in OCAC. Regional genomic plots confirmed overlap of the genetic association signal underlying both plasma protein level and EOC risk for the 26 proteins. Pathway analysis identified enrichment of seven biological pathways among the 26 proteins (Padjusted <0.05), highlighting roles for Focal Adhesion-PI3K-Akt-mTOR and Notch signaling. CONCLUSION: The identified proteins further illuminate the etiology of EOC and represent promising new EOC biomarkers for targeted validation by studies involving direct measurement of plasma proteins in EOC patient cohorts.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Considine DPC, Jia G, Shu X, et al. Genetically predicted circulating protein biomarkers and ovarian cancer risk. Gynecol Oncol. 2020. PMID: 33246661. doi:10.1016/j.ygyno.2020.11.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。